المؤلفون: Huang, ZH, Liu, YT, Yang, C, Li, XY, Pan, CQ, Rao, JJ, Li, NL, Liao, WJ, Lin, L

المصدر: BMC cancer. 18(1):515

مصطلحات موضوعية: Medicin och hälsovetenskap, Klinisk medicin, Cancer och onkologi, Medicinska och farmaceutiska grundvetenskaper, Immunologi inom det medicinska området

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:138147579

المؤلفون: Li Xiao-Qing, Huang Zhang-Xiang, Lu Zhi-Jie, Wu Jing-Xiang, Gao Xiao-Fei, Miao Xue-Rong, He Cheng, Yu Wei-Feng

المصدر: BMC Cancer, Vol 10, Iss 1, p 216 (2010)

مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: http://www.biomedcentral.com/1471-2407/10/216; https://doaj.org/toc/1471-2407

URL الوصول: https://doaj.org/article/c9c66fbc3fde465984c3a59913664e9a

المؤلفون: Huang ZH; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Fujian, 361102, Xiamen, China., Lu GY; The First Affiliated Hospital of Xiamen University, Xiamen, 361003, Fujian, China., Qiu LX; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Fujian, 361102, Xiamen, China., Zhong GH; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Fujian, 361102, Xiamen, China., Huang Y; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Fujian, 361102, Xiamen, China., Yao XM; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Fujian, 361102, Xiamen, China., Liu XH; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Fujian, 361102, Xiamen, China., Huang SJ; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Fujian, 361102, Xiamen, China., Wu T; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Fujian, 361102, Xiamen, China., Yuan Q; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Fujian, 361102, Xiamen, China., Wang YB; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Fujian, 361102, Xiamen, China. ybwang@xmu.edu.cn., Su YY; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Fujian, 361102, Xiamen, China. yingyingsu@xmu.edu.cn., Zhang J; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Fujian, 361102, Xiamen, China., Xia NS; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Fujian, 361102, Xiamen, China.; The Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, Xiamen, 361102, Fujian, China.

المصدر: BMC cancer [BMC Cancer] 2022 Mar 17; Vol. 22 (1), pp. 287. Date of Electronic Publication: 2022 Mar 17.

نوع المنشور: Comparative Study; Journal Article; Meta-Analysis; Systematic Review

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Hepatocellular/*epidemiology , Guanine/*analogs & derivatives , Hepatitis B, Chronic/*drug therapy , Liver Neoplasms/*epidemiology , Tenofovir/*therapeutic use, Antiviral Agents/therapeutic use ; Carcinoma, Hepatocellular/prevention & control ; Carcinoma, Hepatocellular/virology ; Guanine/therapeutic use ; Hepatitis B, Chronic/complications ; Hepatitis B, Chronic/virology ; Humans ; Incidence ; Liver Cirrhosis/complications ; Liver Cirrhosis/virology ; Liver Neoplasms/prevention & control ; Liver Neoplasms/virology ; Treatment Outcome

المؤلفون: Huang ZH; Department of Head & Neck Surgery, Cancer Hospital, Peking Union Medical College, Chinese Academy of Medical Science, Beijing, 100021, China., Ma XW; Department of Endocrinology, Xi'an Hong Hui Hospital, Xi'an, 710054, Shanxi Province, China., Zhang J; Department of Nursing, Shanxi Children's Hospital, Taiyuan, Shanxi Province, China., Li X; Department of Rheumatology, The Second Hospital of Shanxi Medical University, 382 Wuyi Road, Taiyuan, 030001, Shanxi Province, People's Republic of China., Lai NL; Department of Rheumatology, The Second Hospital of Shanxi Medical University, 382 Wuyi Road, Taiyuan, 030001, Shanxi Province, People's Republic of China., Zhang SX; Department of Rheumatology, The Second Hospital of Shanxi Medical University, 382 Wuyi Road, Taiyuan, 030001, Shanxi Province, People's Republic of China. sxzhang1980@126.com.

المصدر: BMC cancer [BMC Cancer] 2018 Nov 26; Vol. 18 (1), pp. 1170. Date of Electronic Publication: 2018 Nov 26.

نوع المنشور: Journal Article; Meta-Analysis

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents, Immunological/*therapeutic use , Cetuximab/*therapeutic use , Esophageal Neoplasms/*drug therapy, Antineoplastic Agents, Immunological/pharmacology ; Cetuximab/pharmacology ; Esophageal Neoplasms/mortality ; Esophageal Neoplasms/pathology ; Humans ; Odds Ratio ; Prognosis ; Randomized Controlled Trials as Topic ; Survival Analysis ; Treatment Outcome